SC 13G:超過5%持股股東披露文件-TANG CAPITAL PARTNERS, LP(6.2%),Tang Capital Management, LLC(6.2%)等
SC 13G:超過5%持股股東披露文件-Beryl Capital Management LLC(9.9%),Beryl Capital Management LP(9.9%)等
SC 13G:超過5%持股股東披露文件-ROGER M. KLEIN(9.0%)
Agile Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Lind Global Fund II LP(1.8%),Lind Global Partners II LLC(1.8%)等
Agile Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Mitchell P. Kopin(0.9%),Daniel B. Asher(0.9%)等
Agile Therapeutics | 4:持股變動聲明-首席財務官 Coiante Scott M
Agile Therapeutics | 3:首次持股聲明-首席財務官 Coiante Scott M
Agile Therapeutics | 4:持股變動聲明-首席商務官 Welsh Amy
Agile Therapeutics | 4:持股變動聲明-高管 Korner Paul
Agile Therapeutics | 4:持股變動聲明-首席執行官 ALTOMARI ALFRED
Agile Therapeutics | 4:持股變動聲明-高管 Conway Robert G
Agile Therapeutics | 4:持股變動聲明-高管 Gilmore Geoffrey
Agile Therapeutics | 4:持股變動聲明-董事 Torrente Josephine
Agile Therapeutics | 4:持股變動聲明-董事 Fischer Seth H. Z.
Agile Therapeutics | 4:持股變動聲明-董事 Hubbard John W
Agile Therapeutics | 4:持股變動聲明-董事 Carson Sandra
Agile Therapeutics | 4:持股變動聲明-董事 BARBARI SHARON
Agile Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(0%),Joseph Edelman(0%)等
Agile Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%)等
Agile Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Mitchell P. Kopin(6.3%),Daniel B. Asher(6.3%)等
暫無數據